Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 10:06 am Unchanged | 13G | REGULUS THERAPEUTICS INC P RGLS | FMR LLC | 2,922,600 4.464% | 0 (Unchanged) | View |
| 2024-03-25 4:18 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | RA CAPITAL MANAGEMENT L.P. | 6,250,000 9.5% | 6,250,000 (New Position) | View |
| 2024-03-22 4:03 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | Deep Track Capital LP | 6,888,424 9.99% | 6,888,424 (New Position) | View |
| 2024-03-20 4:30 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | Vivo Opportunity Fund Holdings L.P. | 5,000,000 7.7% | 5,000,000 (New Position) | View |
| 2024-03-18 9:13 pm Purchase | 13D | REGULUS THERAPEUTICS INC RGLS | Growth Equity Opportunities V LLC | 6,533,102 9.99% | 4,587,523 (+235.79%) | View |
| 2024-02-14 2:54 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | DAFNA Capital Management LLC | 1,111,049 5.49% | 1,111,049 (New Position) | View |
| 2024-02-09 09:49 am Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | FMR LLC | 2,922,600 14.452% | 727,600 (+33.15%) | View |
| 2024-02-06 11:06 am Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | VICTORY CAPITAL MANAGEMENT INC | 1,155,516 5.71% | 305,319 (+35.91%) | View |
| 2024-01-18 10:25 am Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | FEDERATED HERMES INC. FHI | 4,023,860 19.9% | 148,282 (+3.83%) | View |
| 2023-05-12 1:57 pm Sale | 13D | REGULUS THERAPEUTICS INC RGLS | Growth Equity Opportunities V LLC | 1,945,579 9.99% | -12,636,942 (-86.66%) | View |
| 2023-05-10 09:58 am Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | FEDERATED HERMES INC. FHI | 3,875,578 19.9% | 970,752 (+33.42%) | View |
| 2023-02-01 11:43 am Sale | 13G | REGULUS THERAPEUTICS INC RGLS | FEDERATED HERMES INC. FHI | 2,904,826 17.25% | -26,143,439 (-90.00%) | View |
| 2023-01-31 1:51 pm Sale | 13G | REGULUS THERAPEUTICS INC RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,197 5.05% | -7,653,446 (-90.00%) | View |
| 2022-10-11 09:03 am Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | FMR LLC | 2,195,000 14.998% | 2,195,000 (New Position) | View |
| 2022-05-16 2:35 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | FEDERATED HERMES INC. FHI | 29,048,265 19.9% | 29,048,265 (New Position) | View |
| 2022-02-14 4:33 pm Sale | 13G | REGULUS THERAPEUTICS INC RGLS | Point72 Asset Management L.P. | 2,411,577 1.6% | -3,215,436 (-57.14%) | View |
| 2022-02-14 2:30 pm Sale | 13G | REGULUS THERAPEUTICS INC RGLS | Altium Capital Management LP | 1,729,780 2.1% | -1,500,000 (-46.44%) | View |
| 2022-02-14 2:15 pm Sale | 13G | REGULUS THERAPEUTICS INC RGLS | EcoR1 Capital LLC | 2,538,970 1.7% | -1,111,110 (-30.44%) | View |
| 2022-02-14 1:05 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | BIOTECHNOLOGY VALUE FUND L P | 9,661,235 9.99% | 2,610,771 (+37.03%) | View |
| 2022-02-02 09:55 am Unchanged | 13G | REGULUS THERAPEUTICS INC RGLS | VICTORY CAPITAL MANAGEMENT INC | 8,503,643 5.83% | 0 (Unchanged) | View |